Cargando…
Periostin-Binding DNA Aptamer Treatment Ameliorates Peritoneal Dialysis-Induced Peritoneal Fibrosis
Peritoneal fibrosis is a major complication in peritoneal dialysis (PD) patients, which leads to dialysis discontinuation. Periostin, increased by transforming growth factor β1 (TGF-β1) stimulation, induces the expression of extracellular matrix (ECM) genes. Aberrant periostin expression has been de...
Autores principales: | Nam, Bo Young, Park, Jung Tak, Kwon, Young Eun, Lee, Jung Pyo, Jung, Jong Ha, Kim, Youndong, Kim, Seonghun, Park, Jimin, Um, Jae Eun, Wu, Meiyan, Han, Seung Hyeok, Yoo, Tae-Hyun, Kang, Shin-Wook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436072/ https://www.ncbi.nlm.nih.gov/pubmed/28624215 http://dx.doi.org/10.1016/j.omtn.2017.05.001 |
Ejemplares similares
-
Periostin-binding DNA aptamer treatment attenuates renal fibrosis under diabetic conditions
por: Um, Jae Eun, et al.
Publicado: (2017) -
Endothelial Dysfunction Is Associated With Major Adverse Cardiovascular Events in Peritoneal Dialysis Patients
por: Lee, Mi Jung, et al.
Publicado: (2014) -
Newly designed Protein Transduction Domain (PTD)‐mediated BMP‐7 is a potential therapeutic for peritoneal fibrosis
por: Kim, Seonghun, et al.
Publicado: (2020) -
Changes in geriatric nutritional risk index and risk of major adverse cardiac and cerebrovascular events in incident peritoneal dialysis patients
por: Lee, Mi Jung, et al.
Publicado: (2017) -
Low Mitochondrial DNA Copy Number is Associated With Adverse Clinical Outcomes in Peritoneal Dialysis Patients
por: Yoon, Chang-Yun, et al.
Publicado: (2016)